From Business model to Business model portfolio in the european biopharmaceutical industry

2010/01/01 by Valérie Sabatier, Vincent Mangematin, Tristan Rousselle +1 · 8 citations
Business, Management and Accounting · Economics, Econometrics and Finance · Medicine · #Analogy #Biotechnology and Related Fields #Business #Business Strategy and Innovation #Business model #Business plan #Business process #Business relationship management #Business rule #Computer science #Context (archaeology) #Core competency #Diversification (marketing strategy) #Electronic business #Finance #Industrial organization #Innovation and Knowledge Management #Interdependence #Line of business #Marketing #New business development #Pharmaceutical Economics and Policy #Portfolio #Recipe #Sociology

paper · doi:10.1016/j.lrp.2010.02.001

published in RePEc: Research Papers in Economics 43(2-3), 431-447 (Federal Reserve Bank of St. Louis)

openalex publication_date 2010/01/01 · openalex created_date 2025/10/10 · openalex updated_date 2026/07/02

Citations

• Business Models, Business Strategy and Innovation
• Business Models as Models
• Business Model Design: An Activity System Perspective

Cited by

• Business Models as Models
• Value drivers of social businesses: A business model perspective
• Managing complexity in a multi-business-model organization
• Customer complementarity in the digital space: Exploring Amazon’s business model diversification
• Business model diversification: Demand relatedness, entry sequencing, and curvilinearity in the diversification-performance relationship
• Entrepreneurial orientation and new product development performance in SMEs: The mediating role of business model innovation
• Business model innovation – state of the art and future challenges for the field
• Business model innovation in strategic alliances: a multi‐layer perspective